Benefits and harms in pivotal trials of oral centrally acting antiobesity medicines: A systematic review and meta-analysis.

Benefits and harms in pivotal trials of oral centrally acting antiobesity medicines: A systematic review and meta-analysis.

<h4>Objectives</h4> <p>To evaluate the benefits and harms of oral centrally acting antiobesity medicinal products in pivotal trials.</p> <h4>Methods</h4> <p>The European Medicines Agency and Federal Drug Administration websites, PubMed, and ClinicalTrials....

書目詳細資料
Main Authors:	Onakpoya, I, Collins, D, Bobrovitz, N, Aronson, J, Heneghan, C
格式:	Journal article
語言:	English
出版:	Wiley 2018
主題:	subject

相似書籍

Lorcaserin in obesity: minimal benefits and ill-defined harms
由: Onakpoya, I, et al.
出版: (2019)

Benefits and harms of pregabalin in the management of neuropathic pain: a rapid review and meta-analysis of randomised clinical trials
由: Onakpoya, I, et al.
出版: (2019)

Benefits and harms of pregabalin in the management of neuropathic pain: a rapid review and meta-analysis of randomised clinical trials
由: Igho J Onakpoya, et al.
出版: (2019-01-01)

Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis
由: Onakpoya, I, et al.
出版: (2016)

Post-marketing regulation of medicines withdrawn from the market because of drug-attributed deaths: An analysis of justification.
由: Onakpoya, I, et al.
出版: (2017)

Postmarketing withdrawal of human medicinal products because of adverse reactions in animals: a systematic review and analysis.
由: Onakpoya, I, et al.
出版: (2017)

Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.
由: Onakpoya, I, et al.
出版: (2016)

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
由: Onakpoya, IJ, et al.
出版: (2016)

Inhibiting the proton pump: mechanisms, benefits, harms, and questions
由: Aronson, J
出版: (2016)

Making decisions about benefits and harms of medicines.
由: Greenhalgh, T, et al.
出版: (2004)

Plants’ metabolites as potential antiobesity agents
由: Sahib, Najla Gooda, et al.
出版: (2012)

Kimchi and its antiobesity and anticancer functions
由: Kun-Young Park, et al.
出版: (2024-11-01)

Plants' Metabolites as Potential Antiobesity Agents
由: Najla Gooda Sahib, et al.
出版: (2012-01-01)

Adjusting therapeutic dosage regimens to optimise the balance of benefit to harm.
由: Aronson, J
出版: (2005)

Oral hormone pregnancy tests and the risks of congenital malformations: A systematic review and meta-analysis
由: Heneghan, C, et al.
出版: (2018)

DNA barcoding for authentication of Orthosiphon Aristatus herbal medicinal products /
由: Goh, Jia En Jonathan, 1993- 639820, et al.
出版: (2021)

DNA barcoding for authentication of Orthosiphon Aristatus herbal medicinal products /
由: Goh, Jia En Jonathan, 1993- 639820
出版: (2021)

Design a central air conditioning system for mosque /
由: Nazirul Muqmin Abdul Ghaffar, 1996-, author 641004, et al.
出版: (2021)

Robust approach for capacity benefit margin computation with wind energy consideration for large multi-area power systems /
由: Olatunji Obalowu Mohammed, 1983- author 635881, et al.
出版: (2019)

Robust approach for capacity benefit margin computation with wind energy consideration for large multi-area power systems /
由: Olatunji Obalowu Mohammed, 1983- author 635881
出版: (2019)

Antiadherence and antibiofilm of Lavandula Angustifolia essential oil against pathogenic oral bacteria /
由: Nur Nazihani Muhamad Nazir, 1996-, author, et al.
出版: (2021)

Antiadherence and antibiofilm of Lavandula Angustifolia essential oil against pathogenic oral bacteria /
由: Nur Nazihani Muhamad Nazir, 1996-, author
出版: (2021)

DNA barcoding and gallic acid quantification of selected labisia pumila herbal medicinal products /
由: Auni Aqilah Ahmad Tarmizi, 1992-, author 612681, et al.
出版: (2020)

DNA barcoding and gallic acid quantification of selected labisia pumila herbal medicinal products /
由: Auni Aqilah Ahmad Tarmizi, 1992-, author 612681
出版: (2020)

Benefits and harms of oral anticoagulant therapy in chronic kidney disease: a systematic review and meta-analysis
由: Jha, V
出版: (2019)

Antiobesity effect and metabolite analysis of catechin functional kimchi
由: Geun-Hye Hong, et al.
出版: (2024-09-01)

Act on clinical trials of medicinal products for human use - scope of regulation and sources of law
由: Małgorzata Maria Kubacka
出版: (2024-02-01)

Assessing perceptions of benefit and harm of common drug therapies using therapeutic scenarios
由: Aronson, J, et al.
出版: (2003)

Effect of the natural sweetener, steviol glycoside, on cardiovascular risk factors: A systematic review and meta-analysis of randomised clinical trials.
由: Onakpoya, I, et al.
出版: (2014)

Standardization, Safety And Antiobesity Studies Of Piper Sarmentosum Roxburgh Extracts
由: Hamil, Mohd Shahrul Ridzuan
出版: (2016)

Incretin hormone agonists as promising antiobesity drugs - review of literature
由: Aleksandra Grzegorczyk, et al.
出版: (2025-01-01)

Research Progress in Structure, Composition and Antiobesity Mechanism of Marine Polysaccharides
由: WANG Fuyi, YU Shuang, DONG Xinyu, CHEN Biyi,, LI Ying,, ZHAO Qiancheng, SANG Xue
出版: (2024-09-01)

Utilitarian Evaluation of Benefit in Bisubstantive Sentences
由: Anastasia Ye. Vatina
出版: (2024-02-01)

Naltrexone‐bupropion (Mysimba®) in management of obesity: A systematic review and meta‐analysis of unpublished clinical study reports
由: Onakpoya, IJ, et al.
出版: (2020)

Potential Benefits of Ethanol extract of Anredera cordifolia for Antiobesity of High Fat diet-Induced Obesity in White Male Rat Wistar
由: Rusdiana Rusdiana, et al.
出版: (2024-03-01)

Educate to know, act, create
由: Fernando Sancen
出版: (2023-08-01)

Post-marketing withdrawal of analgesic medications because of adverse drug reactions: a systematic review
由: Onakpoya, I, et al.
出版: (2017)

Nutritional composition and antiobesity effects of germinated brown rice in vitro and in vivo
由: Lim, See Meng
出版: (2016)

Tesofensine, a novel antiobesity drug, silences GABAergic hypothalamic neurons.
由: Claudia I Perez, et al.
出版: (2024-01-01)

Tesofensine, a novel antiobesity drug, silences GABAergic hypothalamic neurons
由: Claudia I. Perez, et al.
出版: (2024-01-01)